Inventor
MEIYAPPAN MUTHURAMAN
US12 patents
⚠️ This page may combine multiple inventors who share the name “MEIYAPPAN MUTHURAMAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SHIRE HUMAN GENETIC THERAPIES
8 patentsUS9814764B2Nov 14, 2017
Treatment of sanfilippo syndrome type b by intrathecal administration of alpha-n-acetylglucosaminidase
SHIRE HUMAN GENETIC THERAPIES9 citations90
US11065307B2Jul 20, 2021
Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moiety
SHIRE HUMAN GENETIC THERAPIES2 citations81
US10603364B2Mar 31, 2020
Lysosomal targeting and uses thereof
SHIRE HUMAN GENETIC THERAPIES2 citations70
US10722559B2Jul 28, 2020
Mannose-6-phosphate bearing peptides fused to lysosomal enzymes
SHIRE HUMAN GENETIC THERAPIES5 citations68
US10729746B2Aug 4, 2020
Recombinant placenta growth factor for treating Duchenne muscular dystrophy
SHIRE HUMAN GENETIC THERAPIES0 citations49
US9708590B2Jul 18, 2017
Crystal structure of human α-N-acetylglucosaminidase
SHIRE HUMAN GENETIC THERAPIES0 citations49
US9597376B2Mar 21, 2017
Lipoprotein lipase for treatment of hypertriglyceridemic-related conditions including acute pancreatitis
SHIRE HUMAN GENETIC THERAPIES0 citations43
US9957494B2May 1, 2018
Crystal structure of human four-phosphate adaptor protein 2 glycolipid transfer protein like domain
SHIRE HUMAN GENETIC THERAPIES0 citations41